Researchers have developed a revolutionary drug delivery system using hyaluronic acid-functionalized nanoparticles to deliver therapeutic peptides directly to inflamed intestinal tissue. This breakthrough technology addresses major challenges in peptide therapy by improving stability, targeting, and bioavailability. The system shows promising results for treating ulcerative colitis while minimizing side effects through precise delivery to affected tissues.
This page is available in
